Back to search

Article

PDGF-BB and IL-4 co-overexpression is a potential strategy to enhance mesenchymal stem cell-based bone regeneration

2020-05-07

Abstract excerpt

<title>Abstract</title> <p>Background Mesenchymal stem cell (MSC)-based therapy has the potential for immunomodulation and enhancement of tissue regeneration. Genetically modified (GM) MSCs that over-express specific cytokines, growth factors or chemokines have shown great promise in pre-clinical studies. In this regard, the anti-inflammatory cytokine Interleukin (IL)-4 converts pro-inflammatory M1 macrophages i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
94850e86-b437-5090-a050-cde1268e7ba6
DOI
10.21203/rs.3.rs-26399/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PDGF-BB and IL-4 co-overexpression is a potential strategy to enhance mesenchymal stem cell-based bone regenerationDOI 10.21203/rs.3.rs-26399/v1
Select a neighboring publication to make it the new centre.